A comparitive study of individualised homoeopathic medicines and organopathic mother tinctures in renal calculi

Phase 3

• Conditions: Health Condition 1: N202- Calculus of kidney with calculus of ureter

• Registration Number: CTRI/2022/07/043715
• Lead Sponsor: Dr MPK Homoeopathic College Hospital and Research Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 August 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Diagnosed cases with radiological evidence ( X-ray kidney/ureter/bladder and/or Ultrasound whole abdomen of calculi )

2.Undiagnosed cases with symptoms of renal colic or history of renal colic with urinary complaints.

3.Asymptomatic cases with radiological evidence (X-ray KUB/USG).

4.Patients giving consent to participate in the study.

5.No history of expulsion of calculi after radiological investigations within one month period.

Exclusion Criteria

1.Cases with severe uremia, hydronephrosis, recurrent urinary tract infections or acute retention of urine for more than 24 hours.

2.Gross developmental defects or structural abnormality of kidney.

3.Pregnant women and Lactating mothers.

4.Cases with other severe systemic illness like hypertension, hypothyroidism, hyperparathyroidism, diabetes mellitus, etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.To assess the effect of Individualised Homoeopathic Medicines selected with BBCR and of Organopathic Mother Tinctures selected with Boericke Repertory using VAS scale pre and post treatment scores for dysuria. <br/ ><br> <br/ ><br>2.To assess the effect of Individualised Homoeopathic Medicines selected with BBCR and of Organopathic Mother Tinctures selected with Boericke Repertory using pre and post X- ray KUB/USG evidences for number of stones.Timepoint: 1.Pre scores will be taken at baseline of treatment and post scores will be assessed at the end of 2 weeks. <br/ ><br> <br/ ><br>2.Pre X-ray KUB/USG evidences first will be taken at the baseline of treatment and after evidences at the end of 12 weeks.

Secondary Outcome Measures

Name	Time	Method
To find the more effective method of treatment mentioned above in the studyTimepoint: 12 months